Further mechanistic studies have found that SPRR1B may enhance the migration ability and drug resistance of cancer cells by regulating cytoskeletal remodeling, matrix metalloproteinase (MMPs) secretion, and tumor microenvironment interaction (31, 32). Here, SPRR1B is linked to neoplasm.